ArticleFrontiers in immunology2018

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis.

Harald Hegen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.